The Role of Damage-Associated Molecular Patterns in Perioperative Neurocognitive Disorders: A Narrative Review
Anesthesia & Analgesia · 2026
DOI: 10.1213/ane.0000000000007682 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Anesthesia & Analgesia, 2026. Verfasst von Wiriya Maisat und 1 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Neurocognitive Disorders, Alarmins, Postoperative Cognitive Complications, Cognition. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 90 Literaturangaben.
Abstract (Originalsprache)
Perioperative neurocognitive disorders (PND), such as postoperative delirium (POD) and cognitive dysfunction (POCD), frequently affect older surgical patients and significantly impair postoperative quality of life. During surgical procedures, damage-associated molecular patterns (DAMPs) such as high-mobility group box 1 (HMGB1), mitochondrial DNA, and S100 proteins are released from injured cells and implicated in the pathogenesis of PND. These molecules activate innate immune pathways through pattern recognition receptors (PRRs) such as toll-like receptors (TLRs) and receptors for advanced glycation end products (RAGE). The systemic inflammatory response potentially compromises blood–brain barrier integrity, allowing peripheral immune cells to infiltrate the central nervous system. The resulting neuroinflammation disrupts synaptic function and neuronal connectivity, leading to cognitive impairments. Sustained activation of immune pathways creates a feedback loop where proinflammatory cytokines (eg, IL-1β and TNF-α) amplify DAMP release and immune activation, perpetuating chronic inflammation and cognitive dysfunction. Therapeutic strategies targeting DAMP-mediated pathways, such as glycyrrhizin (an HMGB1 inhibitor), dexmedetomidine (an anti-inflammatory anesthetic), and TLR4 inhibitors (eg, TAK-242), have shown promise in reducing neuroinflammation and protecting cognitive function in preclinical models. However, clinical translation requires validated biomarkers and further trials to ensure their safety and efficacy. This review offers a focused perspective on DAMP-specific mechanisms and emerging therapeutic interventions that modulate these pathways. By contributing to the current understanding of DAMPs in the context of PND, this work supports future research efforts aimed at developing biomarkers and targeted interventions to help mitigate postoperative neurocognitive complications in surgical patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
- Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts.
- Department of Anaesthesia and Immunology, Harvard Medical School, Boston, Massachusetts.
Zitieren
APA
Maisat, W., & Yuki, K. (2026). The Role of Damage-Associated Molecular Patterns in Perioperative Neurocognitive Disorders: A Narrative Review. Anesthesia & Analgesia. https://doi.org/10.1213/ane.0000000000007682
Vancouver
Maisat W, Yuki K. The Role of Damage-Associated Molecular Patterns in Perioperative Neurocognitive Disorders: A Narrative Review. Anesthesia & Analgesia. 2026. doi:10.1213/ane.0000000000007682
BibTeX
@article{Maisat2026,
author = {Maisat, Wiriya and Yuki, Koichi},
title = {The Role of Damage-Associated Molecular Patterns in Perioperative Neurocognitive Disorders: A Narrative Review},
journal = {Anesthesia & Analgesia},
year = {2026},
doi = {10.1213/ane.0000000000007682}
}
EUVIMED